Major Depression?
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
SCHIZOPHRENIA and OTHER PSYCHOTIC DISORDERS of EARLY ONSET Jean Starling & Isabelle Feijo
IACAPAP Textbook of Child and Adolescent Mental Health Chapter OTHER DISORDERS H.5 SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS OF EARLY ONSET Jean Starling & Isabelle Feijo Jean Starling FRANZCP, MPH Child and adolescent psychiatrist, Director, Walker Unit, Concord Centre for Mental Health, Sydney, and senior clinical lecturer, Discipline of Psychiatry, Sydney Medical School, University of Sydney, Sydney, Australia Conflict of interest: none declared Isabelle Feijo FRANZCP Psychiatrist, Walker Unit, Concord Centre for Mental Health, Sydney, Australia and specialist in child and adolescent psychiatry and psychotherapy, Swiss Medical Association Conflict of interest: none declared Jackson Acknowledgement: thanks to Pollock; Polly Kwan who vetted the untitled. Cantonese websites This publication is intended for professionals training or practising in mental health and not for the general public. The opinions expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws of their country of practice. Some medications may not be available in some countries and readers should consult the specific drug information since not all dosages and unwanted effects are mentioned. Organizations, publications and websites are cited or linked to illustrate issues or as a source of further information. This does not mean that authors, the Editor or IACAPAP endorse their content or recommendations, which should be critically assessed by the reader. -
“What About Bob?” an Analysis of Gendered Mental Illness in a Mainstream Film Comedy
“What About Bob?” An Analysis of Gendered Mental Illness in a Mainstream Film Comedy A Thesis Presented in partial fulfillment of the requirements for the degree of Master of Arts in the College of Graduate Studies of Northeast Ohio Medical University. Anna Plummer M.D. Medical Ethics and Humanities 2020 Thesis Committee: Dr. Julie Aultman (Advisor) Dr. Rachel Bracken Brian Harrell Copyright Anna Plummer 2020 ABSTRACT Mental illness has been a subject of fictional film since the early 20th century and continues to be a popular trope in mainstream movies. Portrayals of affected individuals in movies tend to be inaccurate and largely stigmatizing, negatively influencing public perception of mental illness. Recent research suggests that gender stereotypes and mental illness intersect, such that some mental illnesses are perceived as “masculine” and others as “feminine.” This notion may further stigmatize such disorders in individuals, as well as falsely inflate observed gender disparities in certain mental illnesses. Since gendered mental illness is a newly identified concept, little research has been performed exploring the way stereotypical gendered mental illness is depicted in mainstream film. This paper analyzes the movie What About Bob? to show that comedic film perpetuates stigma surrounding feminine mental illness in men and identifies the need for further study of gendered mental illness in movies to ascertain the effect such depictions have on the observed gender disparities in prevalence of certain mental disorders, as well as offers a proposal for coursework for film and medical students. i ACKNOWLEDGMENTS This paper would not have been possible without Dr. Aultman, whose teaching inspired me to pursue further education in Medical Ethics and Humanities, and whose guidance has been invaluable not only for this project, but also for addressing ethical issues in the clinic. -
Depression and Anxiety: a Review
DEPRESSION AND ANXIETY: A REVIEW Clifton Titcomb, MD OTR Medical Consultant Medical Director Hannover Life Reassurance Company of America Denver, CO [email protected] epression and anxiety are common problems Executive Summary This article reviews the in the population and are frequently encoun- overall spectrum of depressive and anxiety disor- tered in the underwriting environment. What D ders including major depressive disorder, chronic makes these conditions diffi cult to evaluate is the wide depression, minor depression, dysthymia and the range of fi ndings associated with the conditions and variety of anxiety disorders, with some special at- the signifi cant number of comorbid factors that come tention to post-traumatic stress disorder (PTSD). into play in assessing the mortality risk associated It includes a review of the epidemiology and risk with them. Thus, more than with many other medical factors for each condition. Some of the rating conditions, there is a true “art” to evaluating the risk scales that can be used to assess the severity of associated with anxiety and depression. Underwriters depression are discussed. The various forms of really need to understand and synthesize all of the therapy for depression are reviewed, including key elements contributing to outcomes and develop the overall therapeutic philosophy, rationale a composite picture for each individual to adequately for the choice of different medications, the usual assess the mortality risk. duration of treatment, causes for resistance to therapy, and the alternative approaches that The Spectrum of Depression may be employed in those situations where re- Depression represents a spectrum from dysthymia to sistance occurs. -
Psychomotor Retardation Is a Scar of Past Depressive Episodes, Revealed by Simple Cognitive Tests
European Neuropsychopharmacology (2014) 24, 1630–1640 www.elsevier.com/locate/euroneuro Psychomotor retardation is a scar of past depressive episodes, revealed by simple cognitive tests P. Gorwooda,b,n,S.Richard-Devantoyc,F.Bayléd, M.L. Cléry-Meluna aCMME (Groupe Hospitalier Sainte-Anne), Université Paris Descartes, Paris, France bINSERM U894, Centre of Psychiatry and Neurosciences, Paris 75014, France cDepartment of Psychiatry and Douglas Mental Health University Institute, McGill Group for Suicide Studies, McGill University, Montreal, Quebec, Canada dSHU (Groupe Hospitalier Sainte-Anne), 7 rue Cabanis, Paris 75014, France Received 25 March 2014; received in revised form 24 July 2014; accepted 26 July 2014 KEYWORDS Abstract Cognition; The cumulative duration of depressive episodes, and their repetition, has a detrimental effect on Major depressive depression recurrence rates and the chances of antidepressant response, and even increases the risk disorder; of dementia, raising the possibility that depressive episodes could be neurotoxic. Psychomotor Recurrence; retardation could constitute a marker of this negative burden of past depressive episodes, with Psychomotor conflicting findings according to the use of clinical versus cognitive assessments. We assessed the role retardation; of the Retardation Depressive Scale (filled in by the clinician) and the time required to perform the Scar; Neurotoxic neurocognitive d2 attention test and the Trail Making Test (performed by patients) in a sample of 2048 depressed outpatients, before and after 6 to 8 weeks of treatment with agomelatine. From this sample, 1140 patients performed the TMT-A and -B, and 508 performed the d2 test, at baseline and after treatment. At baseline, we found that with more past depressive episodes patients had more severe clinical level of psychomotor retardation, and that they needed more time to perform both d2 and TMT. -
White Matter Abnormalities in Adults with Bipolar Disorder Type-II
www.nature.com/scientificreports OPEN White matter abnormalities in adults with bipolar disorder type‑II and unipolar depression Anna Manelis1*, Adriane Soehner1, Yaroslav O. Halchenko2, Skye Satz1, Rachel Ragozzino1, Mora Lucero1, Holly A. Swartz1, Mary L. Phillips1 & Amelia Versace1 Discerning distinct neurobiological characteristics of related mood disorders such as bipolar disorder type‑II (BD‑II) and unipolar depression (UD) is challenging due to overlapping symptoms and patterns of disruption in brain regions. More than 60% of individuals with UD experience subthreshold hypomanic symptoms such as elevated mood, irritability, and increased activity. Previous studies linked bipolar disorder to widespread white matter abnormalities. However, no published work has compared white matter microstructure in individuals with BD‑II vs. UD vs. healthy controls (HC), or examined the relationship between spectrum (dimensional) measures of hypomania and white matter microstructure across those individuals. This study aimed to examine fractional anisotropy (FA), radial difusivity (RD), axial difusivity (AD), and mean difusivity (MD) across BD‑II, UD, and HC groups in the white matter tracts identifed by the XTRACT tool in FSL. Individuals with BD‑II (n = 18), UD (n = 23), and HC (n = 24) underwent Difusion Weighted Imaging. The categorical approach revealed decreased FA and increased RD in BD‑II and UD vs. HC across multiple tracts. While BD‑II had signifcantly lower FA and higher RD values than UD in the anterior part of the left arcuate fasciculus, UD had signifcantly lower FA and higher RD values than BD‑II in the area of intersections between the right arcuate, inferior fronto‑occipital and uncinate fasciculi and forceps minor. -
Included Diagnosis List
Press TAB to Diagnosis Diagnosis Description Code F20.0 Paranoid Schizophrenia F20.1 Disorganized Schizophrenia F20.2 Catatonic Schizophrenia F20.3 Undifferentiated Schizophrenia F20.5 Residual Schizophrenia F20.81 Schizophreniform Disorder F20.89 Other Schizophrenia F20.9 Schizophrenia, Unspecified F21 Schizotypal Disorder F22 Delusional Disorder F23 Brief Psychotic Disorder F24 Shared Psychotic Disorder F25.0 Schizoaffective Disorder, Bipolar Type F25.1 Schizoaffective Disorder, Depressive Type F25.8 Other Schizoaffective Disorders F25.9 Schizoaffective Disorder, Unspecified F28 Other Psychotic Disorder Not Due to a Substance or Known Physiological Condition F29 Unspecified Psychosis Not Due to a Substance or Known Physiological Condition F30.10 Manic Episode Without Psychotic Symptoms, Unspecified F30.11 Manic Episode Without Psychotic Symptoms, Mild F30.12 Manic Episode Without Psychotic Symptoms, Moderate F30.13 Manic Episode, Severe, Without Psychotic Symptoms F30.2 Manic Episode, Severe, With Psychotic Symptoms F30.3 Manic Episode in Partial Remission F30.4 Manic Episode in Full Remission F30.8 Other Manic Episodes F30.9 Manic Episode, Unspecified F31.0 Bipolar Disorder, Current Episode Hypomanic F31.10 Bipolar Disorder, Current Episode Manic, Without Psychotic features, Unspecified F31.11 Bipolar Disorder, Current Episode Manic, Without Psychotic Features, Mild F31.12 Bipolar Disorder, Current Episode Manic, Without Psychotic Features, Moderate F31.13 Bipolar Disorder, Current Episode Manic, Without Psychotic Features, Severe F31.2 -
Understanding the Mental Status Examination with the Help of Videos
Understanding the Mental Status Examination with the help of videos Dr. Anvesh Roy Psychiatry Resident, University of Toronto Introduction • The mental status examination describes the sum total of the examiner’s observations and impressions of the psychiatric patient at the time of the interview. • Whereas the patient's history remains stable, the patient's mental status can change from day to day or hour to hour. • Even when a patient is mute, is incoherent, or refuses to answer questions, the clinician can obtain a wealth of information through careful observation. Outline for the Mental Status Examination • Appearance • Overt behavior • Attitude • Speech • Mood and affect • Thinking – a. Form – b. Content • Perceptions • Sensorium – a. Alertness – b. Orientation (person, place, time) – c. Concentration – d. Memory (immediate, recent, long term) – e. Calculations – f. Fund of knowledge – g. Abstract reasoning • Insight • Judgment Appearance • Examples of items in the appearance category include body type, posture, poise, clothes, grooming, hair, and nails. • Common terms used to describe appearance are healthy, sickly, ill at ease, looks older/younger than stated age, disheveled, childlike, and bizarre. • Signs of anxiety are noted: moist hands, perspiring forehead, tense posture and wide eyes. Appearance Example (from Psychosis video) • The pt. is a 23 y.o male who appears his age. There is poor grooming and personal hygiene evidenced by foul body odor and long unkempt hair. The pt. is wearing a worn T-Shirt with an odd symbol looking like a shield. This appears to be related to his delusions that he needs ‘antivirus’ protection from people who can access his mind. -
Common Pitfalls in ERP for OCD
Common Pitfalls in ERP for OCD ©Justin K. Hughes, MA, LPC & Molly Martinez, PhD Thank you for being here sufferers, support, family, professionals. 2 Common Pitfalls in ERP for OCD ©Justin K. Hughes, MA, LPC & Molly Martinez, PhD HELLO! Justin Hughes, MA, LPC Molly Martinez, PhD Owner, Dallas Counseling, PLLC Clinical Psychologist Clinician, Writer, Speaker Specialists in OCD & Anxiety Recovery (SOAR) www.justinkhughes.com www.soartogether.net Dallas, TX Richardson, TX ©Justin K. Hughes, MA, LPC & Molly Martinez, PhD 4 Learning Objectives 1) Overview OCD and ERP 2) Identify roadblocks to effective ERP 3) Identify solutions to address these common pitfalls 5 Want these slides right now??? www.justinkhughes.com/ocd 6 PART ONE: Review The Basics You Probably Know... ● What OCD is ● What ERP is ● That ERP is the PART ONE: gold-standard of Review the evidence-based treatment Basics for OCD 8 For a PRIZE... What is the average amount of symptom reduction after a trial of ERP for OCD? 9 60-70%!! (Abramowitz & Jacoby, 2015; Foa et al., 2010) 10 You Might Know... ● Compulsions function by reducing distress via: ○ Reassurance PART ONE: ○ Avoidance Review the ● ERP is hard Basics ● ERP requires planning ● ERP requires adjustment ● ERP doesn’t always work as expected 11 PART TWO: ERP Pitfalls & Solutions ● Fear-Related Issues ○ Therapists’ Fears ○ Not Addressing the Core Fear ○ Clients’ Fear of Distress ● Covert Compulsive Behaviors ○ Reassurance ○ Mental Compulsions PART TWO: ○ Distraction ● Treatment Plan(ning) Problems ERP Pitfalls & ○ Treatment Compliance Solutions ○ Not Going Far Enough ○ Not Working with Family ○ Wrong Form of Exposure ○ Unrealistic Expectations (Extinction Burst)Medication Myths/Misconceptions ○ Detours & Comorbidities ○ Therapy “Dosing” ○ No Relapse Prevention Plan 13 Fear-Related Pitfalls & Solutions For a PRIZE.. -
Mental Health and PD
Mental Health and PD Laura Marsh, MD Director, Mental Health Care Line Michael E. DeBakey Medical Center Professor of Psychiatry and Neurology Baylor College of Medicine Recorded on September 18, 2018 Disclosures Research Support Parkinson’s Foundation, Dystonia Foundation, Veterans Health Admin Consultancies (< 2 years) None Honoraria None Royalties Taylor & Francis/Informa Approved/Unapproved Uses Dr. Marsh does intend to discuss the use of off-label /unapproved use of drugs or devices for treatment of psychiatric disturbances in Parkinson’s disease. 1 Learning Objectives • Describe relationships between motor, cognitive, and psychiatric dysfunction in Parkinson’s disease (PD) over the course of the disease. • List the common psychiatric diagnoses seen in patients with PD. • Describe appropriate treatments for neuropsychiatric disturbances in PD. 2 James Parkinson 1755 - 1828 “Involuntary tremulous motion, with lessened muscular power, In parts not in action and even when supported; with a propensity to bend the trunk forward, and to pass from a walking to a running pace; … 3 James Parkinson 1755 - 1828 “Involuntary tremulous motion, with lessened muscular power, In parts not in action and even when supported; with a propensity to bend the trunk forward, and to pass from a walking to a running pace; the senses and intellects being uninjured.” 4 The Complex Face of Parkinson’s Disease • Affects ~ 0.3% general population ~ 1.5 million Americans, 7-10 Million globally ~ 1% population over age 50; ~ 2.5% > 70 years; ~ 4% > 80 years ~ All -
Anxiety Disorders
Anxiety Disorders Anxiety Disorders Overview n What is anxiety? n Categories of anxiety disorders n Generalized Anxiety Disorder n Panic Disorder n Specific Phobia/Social Phobia n Obsessive Compulsive Disorder n DSM-IV diagnoses n Treatments Anxiety n Probably experienced some of this during the exam n What does it feel like? n When is it a “disorder?” n What is the difference between fear and anxiety? n Anxiety defined as n uneasiness stemming from the anticipation of danger n Fear defined as n a reaction to a specific threat from the real, physical world 1 Anxiety n Anxiety is an evolutionary useful feeling n part of the flight or fight response n useful to have a response of energizing to get out of a situation n sometimes this gets in our way n feels not so adaptive Anxiety n Diagnosing n For a person to be diagnosed as having anxiety, the anxiety must be out of proportion to the perceived threat n The anxiety is recognized by the individual seeking treatment to be excessive or unreasonable Anxiety Disorders n Several types/different diagnoses n Based on formal (topographical) features n Should be distinct n Will see much overlap within a category (e.g. within Anxiety) n Also see overlap between other categories (e.g., OCD and eating disorders) 2 Anxiety Disorders n Six disorders: n Generalized anxiety disorder (GAD) n Obsessive-compulsive disorder (OCD) n Phobias n Panic disorder ________________________________ n Acute stress disorder n Post-traumatic stress disorder (PTSD) Generalized Anxiety Disorder (GAD) GAD n One of the most -
''The Mind Is Its Own Place'': Amelioration of Claustrophobia in Semantic Dementia
Hindawi Publishing Corporation Behavioural Neurology Volume 2014, Article ID 584893, 5 pages http://dx.doi.org/10.1155/2014/584893 Case Report ‘‘The Mind Is Its Own Place’’: Amelioration of Claustrophobia in Semantic Dementia Camilla N. Clark,1 Laura E. Downey,1 Hannah L. Golden,1 Phillip D. Fletcher,1 Rajith de Silva,2 Alberto Cifelli,2 and Jason D. Warren1 1 Dementia Research Centre, UCL Institute of Neurology, University College London, 8-11 Queen Square, London WC1N 3BG, UK 2 Essex Neurosciences Centre, Queen’s Hospital, Rom Valley Way, Romford RM7 0AG, UK Correspondence should be addressed to Jason D. Warren; [email protected] Received 1 March 2013; Accepted 17 June 2013; Published 6 March 2014 Academic Editor: Argye E. Hillis Copyright © 2014 Camilla N. Clark et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Phobias are among the few intensely fearful experiences we regularly have in our everyday lives, yet the brain basis of phobic responses remains incompletely understood. Here we describe the case of a 71-year-old patient with a typical clinicoanatomical syndrome of semantic dementia led by selective (predominantly right-sided) temporal lobe atrophy, who showed striking amelioration of previously disabling claustrophobia following onset of her cognitive syndrome. We interpret our patient’s newfound fearlessness as an interaction of damaged limbic and autonomic responsivity with loss of the cognitive meaning of previously threatening situations. This case has implications for our understanding of brain network disintegration in semantic dementia and the neurocognitive basis of phobias more generally. -
Specific Mood Symptoms Confer Risk for Subsequent Suicidal Ideation in Bipolar Disorder with and Without Suicide Attempt History: Multi-Wave Data from Step-Bd
DEPRESSION AND ANXIETY 00:1–9 (2016) Research Article SPECIFIC MOOD SYMPTOMS CONFER RISK FOR SUBSEQUENT SUICIDAL IDEATION IN BIPOLAR DISORDER WITH AND WITHOUT SUICIDE ATTEMPT HISTORY: MULTI-WAVE DATA FROM STEP-BD Jonathan P. Stange, M.A.,1 Evan M. Kleiman, Ph.D.,2 Louisa G. Sylvia, Ph.D.,3 Pedro Vieira da Silva Magalhaes,˜ M.D.,4 Michael Berk, M.D.,5,6 Andrew A. Nierenberg, M.D.,3 ∗ and Thilo Deckersbach, Ph.D.3 Background: Little is known about specific mood symptoms that may confer risk for suicidal ideation (SI) among patients with bipolar disorder (BD). We evaluated prospectively whether particular symptoms of depression and mania precede the onset or worsening of SI, among adults with or without a history of a suicide attempt. Methods: We examined prospective data from a large (N = 2,741) cohort of patients participating in the Systematic Treatment Enhance- ment Program for BD (STEP-BD). We evaluated history of suicide attempts at baseline, and symptoms of depression and mania at baseline and follow-up visits. Hierarchical linear modeling tested whether specific mood symptoms predicted subsequent levels of SI, and whether the strength of the associations differed based on suicide attempt history, after accounting for the influence of other mood symptoms and current SI. Results: Beyond overall current depression and mania symptom severity, baseline SI, and illness characteristics, several mood symptoms, including guilt, reduced self-esteem, psychomotor retardation and agitation, increases in appetite, and distractibility predicted more severe levels of subsequent SI. Problems with concentration, distraction, sleep loss and de- creased need for sleep predicted subsequent SI more strongly among individuals with a suicide attempt history.